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A B S T R A C T   
Obesity is a significant global health and socio-economic challenge, and considered an important risk factor for 
poor health outcomes including male reproductive dysfunction and infertility. As excess adiposity causes 
testicular dysfunction and infertility, novel therapeutic strategies require investigation. Nigella sativa (Ns) seed oil 
and metformin have both demonstrated a potential positive effect on obesity, although both remain poorly 
investigated in male fertility. Therefore, this study aimed to determine the effect of Ns oil and metformin on total 
body weight (TBW), mitochondrial membrane potential (MMP), serum testosterone and semen parameters in an 
obese animal model. Wistar rats (n = 54) were divided into six groups: normal chow (NC), high sugar diet (HSD) 
only, HSD and saline, HSD and metformin (75 mg/Kg/day), HSD and Ns (200 mg/Kg/day) (NS200), HSD and Ns 
(400 mg/Kg/day) (NS400). Intervention was force fed for the last 8 weeks of the 14 weeks dietary exposures. 
Results showed that the HSD increased TBW (P = 0.001) and reduced sperm concentration (P = 0.013) and 
progressive motility (P = 0.009) compared to the NC group. Metformin, NS200 and NS400 improved TBW (P =
0.035, P = 0.006 and P = 0.005, respectively) and testosterone (P < 0.001) compared to the HSD saline group, 
where metformin and NS400 improved sperm concentration (P < 0.001 and P = 0.049, respectively) and MMP 
(P < 0.001). There were no changes in sperm motility and viability for all experimental exposures, although 
NS400 (P = 0.047) negatively affected sperm viability. Metformin and Ns may be novel treatment options in 
obesity-induced infertility, although a potential negative impact on viability is cautioned for high dose Ns. These 
results warrant further investigation of Ns and Metformin for the management of obese infertile males.   
1. Introduction 
Obesity is clinically defined as a body mass index (BMI) > 30 Kg/m2, 
and is considered a significant global health challenge that is driven by 
genetic, environmental, social, economic and cultural influences [1]. As 
a health challenge, there are numerous well defined complications of 
obesity, including metabolic syndrome, type 2 diabetes mellitus 
(T2DM), cardiovascular disease (CVD) and various malignancies [2]. 
Evidence strongly suggests that obesity has a negative impact on male 
reproduction and fertility potential, mediated through diverse mecha-
nisms common to the complex metabolic, immune and endocrine dys-
functions associated with obesity [3,4]. This important relationship 
between obesity and male infertility has led to a demonstratable in-
crease in scientific interest on the topic over recent years [5]. 
Obesity negatively impacts sperm concentration, motility, viability, 
normal morphology and DNA integrity [2,4]. Endocrine changes include 
male hypogonadism, mediated through hypothalamic and testicular 
dysfunction, alongside hyperinsulinaemia, hyperleptinaemia and 
hyperestrogenaemia [3,4]. Systemic low grade inflammation and 
oxidative stress are further important derangements that may contribute 
to reproductive dysfunction [2]. In addition, paternal obesity increases 
the risk for metabolic and neurological pathology in the offspring, 
mediated through altered epigenetic regulation of gene expression in the 
male germ cells acquired during spermatogenesis [3]. With limited 
management options, novel therapeutic strategies that favourably 
modulate the complex underlying mechanisms common to obesity and 
male infertility require investigation, including the use of metformin 
and medicinal plants (phytotherapy) [2]. Various medicinal plants have 
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been reported in a recent systematic review to have evidence for a 
beneficial effect in obesity, including Camellia sinenesis, Caralluma fim-
briata, Garcinia cambogia, Irvingia gabonensis, Nigella sativa and Phaseolus 
vulgaris [6]. 
Nigella sativa (Ns), commonly known as black cumin or black seed in 
English and Habbat al-barakah in Arabic, is a member of the Ranuculaceae 
family. It is an annual herbaceous plant with characteristic white, green, 
yellow or pink flowers of 5–10 petals, with black trigeminal seeds pro-
duced within the fruits. The plant is native to Southwest Asia, the Middle 
East and Mediterranean countries of Africa and Europe [7], where Ns 
seeds have been used extensively in human history for culinary and me-
dicinal purposes dating back over 1400 years [8]. The seeds are described 
as aromatic and bitter to taste, and composed of oils (±40%), proteins 
(±21%), carbohydrates and fibres (±8.4%), ash (±4.5%) and moisture 
(±3.8%) [8]. Traditional uses of Ns, recorded particularly in Unani 
traditional medicine and Islamic medicine, include obesity and compli-
cations such as hypertension and diabetes. Scientific investigation in both 
in vitro and in vivo studies have demonstrated anti-inflammatory, anti-
oxidant, anti-microbial and anti-carcinogenic (anti-proliferative and 
pro-apoptotic) effects, and improvement in atherogenesis, endothelial 
dysfunction, dyslipidaemia, insulin regulation and glucose intolerance 
[7–9]. Human clinical studies have shown potential therapeutic effects in 
obesity, metabolic syndrome, cardiovascular disease, T2DM and repro-
ductive disorders. Importantly, a recent meta-analyses found good evi-
dence for the use of Ns in human obesity and relevant co-morbidities, 
although there is reportedly a high heterogeneity of the limited studies 
included for analysis [10–12]. 
Metformin (N,N-dimethylbguanide) is a biguanide derivative that 
primarily improves insulin sensitivity in diabetic and pre-diabetic (in-
sulin resistant) patients, particularly in patients with clinical obesity 
[13]. Metformin also reduces the incidence of metabolic syndrome in 
overweight patients [14]. This is primarily achieved through the 
reduction of intestinal glucose absorption and hepatic gluconeogenesis 
mediated by improved insulin regulation [13]. Studies have suggested a 
potential benefit of metformin for male reproductive dysfunction asso-
ciated with obesity and insulin resistance, although this requires sig-
nificant further investigation [15]. 
As metformin and Ns are suggested to improve obesity, and may 
have potential benefit in male reproductive parameters, this study 
aimed to investigate the effect of metformin and Ns oil on the male 
reproductive system in an animal model of obesity. 
2. Materials and methods 
2.1. Study overview and design 
Male Wister rats (n = 48) weighing 180–220 g were obtained from 
Tygerberg Hospital (Tygerberg, South Africa) and housed in standard 
cages within the animal facilities unit of the Department of Medical 
Bioscience (MBS), University of Western Cape (UWC) (Bellville, South 
Africa). The animals were housed under controlled temperature be-
tween 21–23 ◦C, and an artificial 12-h light/dark cycle. Principles of 
animal care were conducted in accordance with the South African Na-
tional Standard (SANS 10386:2008) for The Care and Use of Animals for 
Scientific Purposes. Ethical clearance was obtained from the Senate 
Research Committee (UWC) (Ethics Clearance Registration no: 15/4/ 
102). An overview of the groups and study design is provided in Fig. 1. 
The rats were randomly divided into six groups (n = 8 per group). 
Five groups received an obesogenic high sugar diet (HSD) [16,17], and 
one group received normal rat chow (lean group), for 14 weeks. The lean 
group was compared to one HSD group without any intervention or 
control administered. The remaining four HSD groups were used for the 
experimental exposures (Nigella sativa high and low dose groups, and a 
metformin group) and the saline control group. The HSD consisted of rat 
chow (Petco, Bellville, South Africa) soaked in water, into which sucrose 
was dissolved. This was then mixed with condensed milk (Ndlovu Corp 
Supply, Montague Gardens, South Africa) to produce soft food. The final 
ratio was 33% rat chow, 33% condensed milk, 7% sucrose and 27% 
water. Food and water were freely available to the rats throughout the 
study. 
No intervention was provided for the first 8 weeks during the 14 
weeks of HSD exposure. This was followed by 6 weeks of experimental 
exposures in the four groups, namely: control (saline), Nigella sativa 200 
mg/Kg/day (NS200), Nigella sativa 400 mg/Kg/day (NS400) and met-
formin 75 mg/Kg/day. Ns oil was purchased from Crede Natural Oils 
(Cape Town, South Africa) as a cold pressed extraction from the seeds. 
Metformin was obtained through Adcock Ingram (Johannesburg, South 
Africa). The dosages of Ns and metformin were based on previous re-
ports [18–21]. Calculations of individual dosages were done daily based 
on the animal weights, and they were force fed respective exposures and 
control via oral gavage. The control group was given 100 μL of 0.9 % 
saline solution only, prepared by dissolving 9 g of NaCl (Sigma-Aldrich, 
Steinheim, Germany) to 1 l of deionised water. The animals were further 
monitored, weighed and physically inspected for signs of distress daily. 
Following the completion of the experimental phase, the animals 
were euthanized by rapid cervical dislocation as described by Solomon 
and colleagues [22], and tissues obtained for data analysis. Variables for 
statistical analysis included total body weight, spermatozoa parameters 
(concentration, motility, viability and mitochondrial membrane poten-
tial) and serum testosterone. 
2.2. Determination of semen parameters 
The head of the caput epididymis was isolated and placed in a petri 
dish (35 × 10 mm) containing 1 mL Dulbecco’s Modified Eagle’s Me-
dium DMEM (Gibco, Auckland, New Zealand), and supplemented with 
1% bovine serum albumin (BSA) (Sigma, St. Louis, USA). A total of 1 mL 
of the medium was placed in a second petri dish, and the distal caudal 
epididymis was isolated and incubated at 37 ◦C (Gwayi & Bernard, 
Fig. 1. Overview of the experimental design of the study. Following 14 weeks 
of HSD including 8 weeks’ intervention for the experimental groups, total body 
weight, semen parameters and serum testosterone was investigated. HSD =
high sugar diet; Ns = Nigella sativa oil. 
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2002). A slit was made in the cauda to allow the sperm to swim out into 
the medium for about 10 s in order to collect spermatozoa for analysis. 
Sperm concentration and motility was determined using the Com-
puter Assisted Semen Analysis (CASA) equipment and software (SCA® 
version 6.0) (Microptic S.L, Barcelona, Spain). A Basler A312FC digital 
camera, mounted onto a Nikon Eclipse 50i microscope (IMP, Cape 
Town, South Africa), was used for all CASA analyses. The microscope 
was provided with a 10X objective, phase contrast optics and a pre- 
heated stage of 37 ◦C. In order to analyse the semen sample, 2 μl of 
the spermatozoa obtained from the swim out from the cauda epididymis 
was prepared in medium at 37 ◦C and then placed onto a Leja slide (Leja, 
Nieuw Vernep, The Netherlands). Thereafter, the slide was viewed 
under a microscope and a minimum of 200 motile spermatozoa over a 
minimum of two different frames from every 4th microscopic field were 
analysed for each sample. The average of two different analyses was 
considered for statistical analysis. 
Sperm vitality was assessed using the eosin-nigrosin stain. For each 
sample, 50 μl of eosin-nigrosin stain was mixed gently with 50 μl of a 
spermatozoa sample separately, and 20 μl of the mixture was then 
smeared to a microscopy slide. After drying, the slide was analysed 
under the microscope (Zeiss, Oberkochen, Germany) at 100x magnifi-
cation. A total of 200 spermatozoa were counted on each slide, and the 
percentage of live (viable) sperm was calculated from spermatozoa that 
remained white (indicates an intact cell membrane with the stain). Dead 
spermatozoa appeared pink or red (stain taken up into the cell due to a 
damaged cell membrane) 
Sperm mitochondrial membrane potential (MMP) was assayed using 
the DePsipher staining kit (Trevigen, Gaithersburg, USA). In brief, 
spermatozoa were re-suspended in 50 μl of DePsipher solution and 
incubated for 20 min at 37 ◦C in the dark. After incubation, 10 μl of each 
sample was viewed with 488 nm excitation and 590 nm emission filters 
at 1000 x magnification with oil immersion on an epifluorescence mi-
croscope (Zeiss, Oberkochen, Germany). Cells with disturbed MMP 
showed green fluorescence with an emission of 520 nm, whilst sper-
matozoa with intact MMP showed red fluorescence at 590 nm. An 
average of 200 spermatozoa was manually counted to determine a 
percentage (red cells divided by total cells counted) of spermatozoa with 
intact MMP (red) for data analysis. 
2.3. Determination of serum testosterone 
Following cervical dislocation, a blood sample was obtained from 
cardiac puncture, and allowed to clot for 30 min in 1.5 mL micro-
centrifuge tubes (Corning, New York, USA). This was then centrifuged at 
3000 × g for 15 min and serum was separated and stored at − 20 ◦C until 
biochemical evaluation. Testosterone concentration was determined 
using the Testosterone ELISA kit (DRG Instruments GmBH, Marburg, 
Germany). The assay was performed according to the manufacturer’s 
instructions. In brief, 25 μl of each standard and sample was added into 
each well containing 200 μl enzyme conjugate and incubated for 60 min 
at room temperature without covering the plate. Following incubation, 
the wells were washed 3 times with washing buffer. Residual droplets 
were removed, and then 200 μl of substrate solution was added to each 
well and incubated for a further 15 min at room temperature. The re-
action was stopped by adding 100 μl stop solution to each well and the 
signal was read at 450 nm using a Microplate Reader Model LT-4000 
(Labtech, East Sussex, UK). Using the standard curve, the concentra-
tion of testosterone in the experimental samples was calculated for data 
analysis. The obtained results are expressed as ng/mL. 
2.4. Statistics 
Statistical analysis was carried out by using MedCalc statistical 
software (Version 12.1.3.0, Mariakerke, Belgium). Normal distribution 
was checked by Kolmogorov-Smirnoff test, and the variables compared 
by an independent sample t-test or the Mann-Whitney test depending on 
the normal or abnormal data distribution, respectively. Data is repre-
sented as bar graphs with standard deviation for parametric data or box- 
and-whisper graphs for non-parametric data. A P-value of < 0.05 was 
considered statistically significant 
3. Results 
3.1. Total body weight 
The HSD group total body weight was significantly heavier 
compared to the lean group (P = 0.0001). Metformin (P = 0.0345), 
NS200 (P = 0.0057) and NS400 (P = 0.0048) significantly improved 
total body weight compared to saline. There was no significant differ-
ence between metformin and NS200 or NS400 (Fig. 2). 
3.2. Semen parameters 
The sperm concentration was significantly lower in the HSD group 
compared to the lean group (P = 0.0128). Metformin significantly 
improved sperm concentration compared to saline (P = 0.0003). NS200 
caused a non-significant increase (P = 0.1043), whereas the NS400 
group showed a significant increase for sperm concentration compared 
to saline (P = 0.0493). Metformin further showed a significantly higher 
sperm concentration as compared to the NS200 (P = 0.0168) and NS400 
(P = 0.0295) groups (Fig. 3). 
Progressive motility was significantly lower in the HSD group 
compared to the lean group (P = 0.0092), with no significant difference 
for non-progressive motility (P = 0.9655). There was no significant 
difference in progressive motility for metformin (P = 0.3865), NS200 (P 
= 0.2332) and NS400 (P = 0.8253) groups compared to saline. Simi-
larly, there was no significant difference in non-progressive motility 
between for metformin (P = 0.5414), NS200 (P = 0.1198) and NS400 (P 
= 0.5895) groups compared to saline. Non-progressive motility was 
significantly lower in the NS200 group compared to metformin (P =
0.0355), but not the NS400 group (P = 0.2702) (Fig. 4 and 5). 
Sperm viability did not vary significantly in the HSD group compared 
to the lean group (P = 0.9648). There was no statistical difference in 
sperm viability between the metformin and saline group (P = 0.5966), 
while NS200 showed a non-significant decrease in sperm viability (P =
0.0637), with a significant decrease for NS400 (P = 0.0469). Moreover, 
no significant difference between the metformin and the NS200 (P =
0.1489) or NS400 (P = 0.1234) groups was observed (Fig. 6). 
The MMP was not significantly different in the HSD group compared 
to lean group (P = 0.2808). Metformin significantly improved MMP 
compared to saline (P = 0.0003), while NS200 showed a non-significant 
increase in MMP (P = 0.3067). The administration of 400 mg Ns/Kg/day 
(NS400) resulted in a significant increase in the percentage of MMP- 
intact sperm (P < 0.0001). In the metformin group, the percentage of 
MMP-intact sperm was significantly higher compared to the NS200 (P =
0.0003) group, with no statistical difference with NS400 (P = 0.8942) 
(Fig. 7). 
3.3. Serum testosterone 
The serum testosterone concentration was non-significantly higher 
in the HSD group compared to the lean group (P = 0.4599). In contrast, 
metformin (P = 0.0001), NS200 (P = 0.0002) and NS400 (P < 0.0001) 
administration led to significantly increased serum testosterone con-
centrations compared to the saline group. There was no significant dif-
ference between the metformin group and the NS200 (P = 0.3649) and 
NS400 (P = 0.7948) groups (Fig. 8). 
4. Discussion 
Obesity has been established to have a negative impact on male 
reproduction [2–4]. In humans and animals, high energy sugar diets 
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induce obesity and associated metabolic co-morbidities (dyslipidaemia, 
hyperglycaemia and hyperinsulinaemia) and complications (CVD and 
T2DM) [16,23–27]. As expected, the results of this study showed that 
the HSD diet resulted in a significant increase in total body weight 
compared to the lean control consuming normal chow. The HSD group 
further showed a significant decrease in sperm concentration and pro-
gressive motility, with no significant effect on non-progressive motility, 
viability or MMP. These results support the findings of Adekunbi et al. 
(2016), showing a decline in sperm concentration, motility, viability, 
morphology and serum testosterone using a high sucrose diet in rats 
[28]. Interestingly, the HSD group did not show reduced serum testos-
terone concentrations compared to the lean group, where rats fed high 
sucrose or fructose diets have been previously reported to have reduced 
serum testosterone concentrations [28,29]. In this context, Ns seed oil 
and metformin may improve obesity and the negative impact of obesity 
on male reproduction [7–12,14,15]. This study further investigated 
metformin and Ns oil as a potential management option for obesity 
induced male reproductive dysfunction in this HSD animal model. 
Metformin is an anti-hyperglycaemic medication commonly pre-
scribed in T2DM and insulin resistance associated with obesity and 
metabolic syndrome [13,14]. Although metformin has been widely 
studied and reported to result in weight loss in non-diabetic patients, its 
effects on the male reproductive system are not well known [15,30]. 
However, in obese and insulin resistant men, metformin appears to 
improve reproductive parameters of males with T2DM [15]. In this study, 
a significant decrease in total body weight was reported in the metformin 
group, consistent with the benefit of metformin in obese diabetic and 
pre-diabetic patients [13,14]. Metformin treatment further showed sig-
nificant improvements in sperm concentration and MMP-intact sperma-
tozoa, with no significant effect on motility or viability, alongside 
Fig. 2. Comparative analysis of the groups for total body weight. S = Saline group; Met = Metformin group; NS200 = Nigella sativa 200 mg/Kg/day group; NS400 =
Nigella sativa 400 mg/Kg/day group; NC = Normal Chow group; HSD = High Sugar Diet group. 
Fig. 3. Comparative analysis of the groups for sperm concentration (M/mL). S = Saline group; Met = Metformin group; NS200 = Nigella sativa 200 mg/Kg/day 
group; NS400 = Nigella sativa 400 mg/Kg/day group; NC = Normal Chow group; HSD = High Sugar Diet group. 
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improved serum testosterone levels. These results support limited studies 
where metformin significantly improves sperm parameters, increases 
testosterone and reduces estrogen concentrations in obesity [14,31]. 
Furthermore, metformin has been shown to improve epididymal sperm 
quality and antioxidant function in the testes, including increased su-
peroxide dismutase (SOD) and glutathione peroxidase [32]. In humans, 
metformin treatment for 6 months has been suggested to improve oli-
goasthenoteratozoospermia in patients with metabolic syndrome [33]. 
Further evidence in streptozotocin (STZ) induced diabetic animal models 
supports the use of metformin in improving sperm parameters, sperm 
DNA integrity and epididymal sperm count, reduces lipid peroxidation 
and increased endogenous antioxidant concentrations, and increases 
intra-testicular testosterone levels alongside serum testosterone, LH and 
FSH concentrations [34–37]. However, in healthy animal models, 
metformin appears to negatively affect reproductive functions, including 
epididymal sperm concentration and motility, causing increased testic-
ular lipid peroxidation and reduced SOD, catalase and glutathione ac-
tivity [38]. In an in vivo experiment in which ejaculated human sperm was 
exposed to metformin, there was a reduction in total motile and pro-
gressively motile spermatozoa, with no effect on viability, MMP or 
mitochondrial superoxide generation. This was mediated through inhi-
bition of the protein kinase pathway and protein tyrosine phosphoryla-
tion [39]. Similarly to metformin, myo-inositol’s are potential insulin 
sensitizing and antioxidant formulations for male infertility manage-
ment, which have been suggested for clinical use particularly in assisted 
reproduction techniques [40,41]. This further suggest that modulation of 
insulin sensitivity may be an important target for obesity induced male 
infertility. 
Fig. 4. Comparative analysis of the groups for progressive motility (%). S = Saline group; Met = Metformin group; NS200 = Nigella sativa 200 mg/Kg/day group; 
NS400 = Nigella sativa 400 mg/Kg/day group; NC = Normal chow group; HSD = High Sugar Diet group. 
Fig. 5. Comparative analysis of the groups for non-progressive motility. S = Saline group; Met = Metformin group; NS200 = Nigella sativa 200 mg/Kg/day group; 
NS400 = Nigella sativa 400 mg/Kg/day group; NC = Normal Chow group; HSD = High Sugar Diet group. 
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Ns is a herbal medicine that has a wide use of applications in 
traditional medicine systems. Traditional and scientific evidence sug-
gests that Ns seed oil may be beneficial in obesity and associated 
complications, with the notion that Ns may also improve male repro-
ductive parameters [7–12]. Similarly to metformin, the results of this 
study showed that Ns oil improved body weight, sperm concentration, 
percentage of MMP-intact sperm, and serum testosterone levels with 
no significant effect on progressive and non-progressive motility. 
However, there remains a paucity of studies investigating the potential 
use of Ns oil on obesity induced impaired reproductive parameters. In a 
HFD induced model of hyperlipidaemia in rats, Ns oil extract (0.5 
mL/Kg) improved sperm concentration, motility, morphology and 
serum testosterone concentrations [42]. In an isolated randomised 
controlled trial of Iranian infertile men with abnormal semen param-
eters, Ns oil treatment (2.5 mL twice daily for 2 months) showed an 
improvement in sperm concentration, motility, morphology and semen 
volume compared to placebo [43]. Interestingly, there was a negative 
impact of Ns oil on sperm viability in this study. Although this is 
generally contradictory to the current evidence available, there is a 
report of reduced motility with no negative effect on viability using an 
in vitro model on normozoospermic semen samples exposed to Ns ex-
tracts (5 and 10 mg/mL) [44]. 
Fig. 6. Comparative analysis of the groups for sperm viability (% viable). S = Saline group; Met = Metformin group; NS200 = Nigella sativa 200 mg/Kg/day group; 
NS400 = Nigella sativa 400 mg/Kg/day group; NC = Normal Chow group; HSD = High Sugar Diet group. 
Fig. 7. Comparative analysis of the groups for MMP (% intact). S = Saline group; Met = Metformin group; NS200 = Nigella sativa 200 mg/Kg/day group; NS400 =
Nigella sativa 400 mg/Kg/day group; NC = Normal Chow group; HSD = High Sugar Diet group. 
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Although few Ns studies investigating obesity models and male 
reproduction were identified, there are reports of Ns on fertility pa-
rameters from healthy animal models. At 300 mg/Kg, an Ns seed 
aqueous extraction increased sperm concentration and motility within 
the cauda epididymis and testicular ducts, as well as increased numbers 
of spermatids and spermatocytes [45]. An ethanolic extract of Ns (200 
mg/Kg) increased sperm concentration, testosterone and LH levels with 
no effect on FSH [46]. Similarly, Ns ethanolic extracts at higher dosages 
(500 and 1500 mg/Kg per day) increased testosterone and FSH, with a 
significant decrease in LH [47]. A high dose Ns oil extraction (1 mL/Kg) 
improved sperm concentration, motility and testosterone, and was re-
ported to increase testicular antioxidants and reduce testicular reactive 
oxygen species [48]. At a lower dosage similar to the NS400 dosage in 
this study, 0.4 mL/Kg Ns oil improved sperm concentration with a 
decrease in lipid peroxidation and increased glutathione peroxidase in 
the testes, but had no effect on sperm motility or serum testosterone, 
inhibin, LH or FSH [49]. 
Ns, or the isolated compound thymoquinone, have been shown to 
protect against toxic damage in the testes. This is seemingly mediated 
primarily through improvement of oxidative stress in serum and in the 
testes. This includes protection against impaired sperm motility, normal 
morphology, viability, sperm membrane integrity, MMP and testos-
terone [48,50,51]. In a streptozotocin-induced diabetic rat model that 
induced testicular toxicity, Ns seed extractions significantly improved 
insulin concentration, testosterone, LH, FSH, dyslipidaemia, testicular 
redox balance (reduced malondialdehyde and increased SOD concen-
trations), and epididymal sperm concentration. These results were 
similar to the effect of metformin on these parameters, and were found 
to have a more positive outcome when metformin and Ns was combined 
[37,52,53]. 
The antioxidant activity of Ns oil may be due to various micro-
nutrients and secondary plant metabolites. These include calcium (1860 
mg/Kg), phosphorus (527 mg/Kg), iron (105 mg/Kg), niacin (57 mg/ 
Kg), thiamine (15.4 mg/Kg), copper (18 mg/Kg), zinc (60 mg/Kg) and 
folic acid (160 μg/Kg) [7]. The oils are predominantly comprised of 
linoleic (50–60%), oleic (20–23%) and palmitic acids (12.5 %), along-
side stearic, myristic and arachidonic acids, β-sitosterol, sterol esters and 
sterol glucosides [8]. Well-studied active constituents and antioxidants 
are isolated as aromatics from the essential oil of the seeds, particularly 
thymoquinone, dithymoquinone, thymol, carvacrol, α-pinene, β-pinene 
and α-thujene. Important alkaloids isolated from the seed oils include 
nigellicine and nigellidine. Other secondary plant metabolites with 
antioxidant activity include saponins, flavonoids, cardiac glycosides and 
alkaloids [7,8]. 
The improvement of metformin on body weight and testosterone 
was statistically similar to that of NS200 and NS400, as was the posi-
tive impact of metformin and NS400 on sperm MMP. However, met-
formin had a more pronounced positive impact on sperm concentration 
compared to NS200 and NS400. There was no statistical difference 
between metformin and NS200 or NS400 groups for sperm progressive 
motility and viability, where the metformin group had a statistically 
higher non-progressive motility compared to NS200, but not NS400. 
These results suggest the impact of metformin and Ns oil in this study 
were generally very similar in terms of parameters improved. 
Furthermore, for total body weight, all experimental exposures were 
similar to that of the normal chow group, and metformin and NS400 
improved sperm MMP and serum testosterone better than NC group. 
These results suggest that metformin and Ns interventions may restore 
the negative impact of HSD to normal for these parameters. 
The results of this study in the context of the current literature sug-
gests that both metformin and Ns may be beneficial in male reproductive 
dysfunction induced by obesity. The mechanisms, however, remain 
generally elusive. Metformin has numerous cellular effects that explain 
its action on hyperglycaemia and insulin resistance syndrome [54]. 
Suggested mechanisms include a reduction of oxidative stress through 
increased endogenous antioxidant regulation, immune regulation 
through a reduction in inflammatory cytokines and M1 macrophage 
expression, mild inhibition of mitochondrial respiratory chain complex 
1 associated with reduced hepatic gluconeogenesis while increasing 
glucose utilisation peripherally, and activation of the 5′-AMP activated 
protein kinase (AMPK) pathway [13,15,54–57]. Metformin reduces both 
inflammation and associated oxidative stress through direct immune 
modulation, and indirectly through improvement of hyperglycaemia, 
insulin resistance and dyslipidaemia mediated by AMPK activation and 
NFκB inhibition [58,59]. In diabetes, metformin is shown to improve 
testicular inflammation and oxidative stress [60]. 
Similarly to metformin, Ns has also been established to modulate im-
mune regulation, reduce oxidative stress and activate the AMPK pathway 
[13,61,62]. Ns seed oil and isolated thymoquinone activate PPARϒ and 
GLUT4 mRNA expression, upregulates antioxidant activity, improves in-
sulin regulation and hyperglycaemia in streptozotocin-induced diabetic 
rats [62]. Ethanolic extracts of Ns have shown PPARϒ agonist activity 
through AMPK activation in an in vivo model on skeletal muscle and he-
patocytes, improving insulin signalling pathways [63]. Alkaloid isolates 
from Ns seeds increase glucose absorption in hepatocytes through acti-
vation of AMPK, specifically nigelanoid, nigeglanine, nigellidine, 
17-O-(β-D-glucopyr-anosyl)-4-O-methylnigellidine, 4-O-methylnigellidine 
and 4-O-methylnigeglanine [64]. For thymoquinone, an immune regu-
lating effect through the activation of AMPK pathways, downregulation of 
TLR4 and inflammatory cytokine expression, as well as inhibition of 
phosphatidylinositol 3-kinase (PI3K) phosphorylation [65], has also been 
established. Sertoli cells further increase lactate production with exposure 
to Ns, with reduced GLUT1, GLUT3 and MCT4 expressions activated by 
AMPK in spermatozoa [15]. 
AMPK has important regulatory functions in cellular metabolism, 
proliferation and immune regulation, particularly relevant to the bal-
ance of glucose, lipids and protein metabolism [66]. Activation of AMPK 
results in GLUT4 translocation to the plasma membrane, increasing 
cellular uptake of glucose [66]. This pathway is activated by an 
increased AMP:ATP ratio, exercise and stress, and through exogenous 
compounds including polyphenols and synthetic molecules like met-
formin [67]. AMPK activation is known to result in a reduction of 
oxidative stress and may improve sperm parameters such as motility, 
morphology, and the acrosome reaction [15]. Metformin and Ns acti-
vation of the AMPK pathway results in inhibition of enzymes involved in 
gluconeogenesis and improving insulin signalling and intracellular 
glucose transport in muscles [13,61,62]. AMPK is considered a central 
regulator in testicular and spermatozoa function, connecting reproduc-
tion pathways with energy balance, and is further reported to have 
important roles in steroidogenesis and spermatogenesis [67]. Activation 
of AMPK pathway further improves MMP in mature mammalian sper-
matozoa, as reported in the metformin and NS400 groups [68]. AMPK 
further increases the proliferation of Leydig and Sertoli cells, leading to 
increased sperm concentration and testosterone production, respec-
tively, again both observed in the metformin and NS400 groups [68,69]. 
Fig. 8. Comparative analysis of the groups for testosterone concentration. S =
Saline group; Met = Metformin group; NS200 = Nigella sativa 200 mg/Kg/day 
group; NS400 = Nigella sativa 400 mg/Kg/day group; NC = Normal Chow 
group; HSD = High Sugar Diet group. 
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Although motility was not significantly improved in this study, activa-
tion of AMPK pathway may partly explain the positive impact of met-
formin and Ns on the male reproductive system in diet induced obesity 
for sperm concentration, MMP and testosterone. 
5. Conclusion 
Ns oil and metformin were similarly effective in reducing total body 
weight, increasing sperm concentration, sperm MMP and serum testos-
terone levels in rats fed an obesogenic diet. Progressive motility and 
viability were not affected by Ns oil or metformin. Ns oil and metformin 
may offer benefit in male obesity with reproductive complications, 
potentially mediated through numerous potential pathways, including 
immune regulation, antioxidant activity and increased AMPK activity. 
Further clinical studies are warranted to investigate the mechanisms and 
therapeutic potential of these compounds in male obesity and associated 
infertility. 
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